BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kang X, Chen K, Li Y, Li J, D'Amico TA, Chen X. Personalized targeted therapy for esophageal squamous cell carcinoma. World J Gastroenterol 2015; 21(25): 7648-7658 [PMID: 26167067 DOI: 10.3748/wjg.v21.i25.7648]
URL: https://www.wjgnet.com/1007-9327/full/v21/i25/7648.htm
Number Citing Articles
1
Ah-Won Kwak, Goo Yoon, Mee-Hyun Lee, Seung-Sik Cho, Jung-Hyun Shim, Jung-Il Chae. Picropodophyllotoxin, an Epimer of Podophyllotoxin, Causes Apoptosis of Human Esophageal Squamous Cell Carcinoma Cells Through ROS-Mediated JNK/P38 MAPK PathwaysInternational Journal of Molecular Sciences 2020; 21(13): 4640 doi: 10.3390/ijms21134640
2
Hiroki Ueda, Daisuke Ban, Atsushi Kudo, Takanori Ochiai, Shinji Tanaka, Minoru Tanabe. Refractory Long‐Term Cholangitis After Pancreaticoduodenectomy: A Retrospective StudyWorld Journal of Surgery 2017; 41(7): 1882 doi: 10.1007/s00268-017-3912-z
3
Tuhina Khan, Nicola Relitti, Margherita Brindisi, Stefania Magnano, Daniela Zisterer, Sandra Gemma, Stefania Butini, Giuseppe Campiani. Autophagy modulators for the treatment of oral and esophageal squamous cell carcinomasMedicinal Research Reviews 2020; 40(3): 1002 doi: 10.1002/med.21646
4
Bo-Hyun You, Jung-Ho Yoon, Hoin Kang, Eun Kyung Lee, Sang Kil Lee, Jin-Wu Nam. HERES, a lncRNA that regulates canonical and noncanonical Wnt signaling pathways via interaction with EZH2Proceedings of the National Academy of Sciences 2019; 116(49): 24620 doi: 10.1073/pnas.1912126116
5
Chung S. Yang, Xiaoxin Luke Chen. Research on esophageal cancer: With personal perspectives from studies in China and KenyaInternational Journal of Cancer 2021; 149(2): 264 doi: 10.1002/ijc.33421
6
Guiqin Hou, Tengda Niu, Ang Jia, Yingying Zhang, Xunan Chen, Huiyun Wei, Yilin Jia, Yichao Xu, Yan Li, Pengju Wang, Aniruddha Chatterjee. NRG1 promotes tumorigenesis and metastasis and afatinib treatment efficiency is enhanced by NRG1 inhibition in esophageal squamous cell carcinomaBiochemical Pharmacology 2023; 218: 115920 doi: 10.1016/j.bcp.2023.115920
7
Mingrui Shao, Wenya Li. Transcriptional factor regulation network and competitive endogenous RNA (ceRNA) network determining response of esophageal squamous cell carcinomas to neoadjuvant chemoradiotherapyPeerJ 2019; 7: e6668 doi: 10.7717/peerj.6668
8
Yi-Xin Zhao, He-Ping Zhao, Meng-Yao Zhao, Yan Yu, Xi Qi, Ji-Han Wang, Jing Lv. Latest insights into the global epidemiological features, screening, early diagnosis and prognosis prediction of esophageal squamous cell carcinomaWorld Journal of Gastroenterology 2024; 30(20): 2638-2656 doi: 10.3748/wjg.v30.i20.2638
9
Chengyi Mao, Xiaoxi Zeng, Chao Zhang, Yushang Yang, Xin Xiao, Siyuan Luan, Yonggang Zhang, Yong Yuan. Mechanisms of Pharmaceutical Therapy and Drug Resistance in Esophageal CancerFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.612451
10
Chorlada Paiboonrungruang, Emily Simpson, Zhaohui Xiong, Caizhi Huang, Jianying Li, Yahui Li, Xiaoxin Chen. Development of targeted therapy of NRF2high esophageal squamous cell carcinomaCellular Signalling 2021; 86: 110105 doi: 10.1016/j.cellsig.2021.110105
11
Lehang Lin, De-Chen Lin. Biological Significance of Tumor Heterogeneity in Esophageal Squamous Cell CarcinomaCancers 2019; 11(8): 1156 doi: 10.3390/cancers11081156
12
Lei Wei, Bo Wang, Liwen Hu, Yang Xu, Zhongdong Li, Yi Shen, Hairong Huang. MEX3A is upregulated in esophageal squamous cell carcinoma (ESCC) and promotes development and progression of ESCC through targeting CDK6Aging 2020; 12(21): 21091 doi: 10.18632/aging.103196
13
Ting Yan, Heyang Cui, Yong Zhou, Bin Yang, Pengzhou Kong, Yingchun Zhang, Yiqian Liu, Bin Wang, Yikun Cheng, Jiayi Li, Shixing Guo, Enwei Xu, Huijuan Liu, Caixia Cheng, Ling Zhang, Ling Chen, Xiaofei Zhuang, Yu Qian, Jian Yang, Yanchun Ma, Hongyi Li, Fang Wang, Jing Liu, Xuefeng Liu, Dan Su, Yan Wang, Ruifang Sun, Shiping Guo, Yaoping Li, Xiaolong Cheng, Zhihua Liu, Qimin Zhan, Yongping Cui. Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinomaNature Communications 2019; 10(1) doi: 10.1038/s41467-019-09255-1
14
Fei Yang, Shiwang Wen, Yuefeng Zhang, Yanzhao Xu, Huilai Lv, Yonggang Zhu, Mingbo Wang, Peng Su, Chao Huang, Ziqiang Tian. Identifying potential metastasis‐related long non‐coding RNAs, microRNAs, and message RNAs in the esophageal squamous cell carcinomaJournal of Cellular Biochemistry 2019; 120(8): 13202 doi: 10.1002/jcb.28594
15
Chorlada Paiboonrungruang, Zhaohui Xiong, David Lamson, Yahui Li, Brittany Bowman, Julius Chembo, Caizhi Huang, Jianying Li, Eric W. Livingston, Jon E. Frank, Vivian Chen, Yong Li, Bernard Weissman, Hong Yuan, Kevin P. Williams, M. Ben Major, Xiaoxin Chen. Small molecule screen identifies pyrimethamine as an inhibitor of NRF2-driven esophageal hyperplasiaRedox Biology 2023; 67: 102901 doi: 10.1016/j.redox.2023.102901
16
Inamu Rashid Khan, Hana Q. Sadida, Sheema Hashem, Mayank Singh, Muzafar A. Macha, Ammira S. Al-Shabeeb Akil, Ibraq Khurshid, Ajaz A. Bhat. Therapeutic implications of signaling pathways and tumor microenvironment interactions in esophageal cancerBiomedicine & Pharmacotherapy 2024; 176: 116873 doi: 10.1016/j.biopha.2024.116873
17
Zhaoming Lu, Yandan Ren, Li Yang, Ang Jia, Yi Hu, Yu Zhao, Wuduo Zhao, Bin Yu, Wen Zhao, Jianying Zhang, Guiqin Hou. Inhibiting autophagy enhances sulforaphane-induced apoptosis via targeting NRF2 in esophageal squamous cell carcinomaActa Pharmaceutica Sinica B 2021; 11(5): 1246 doi: 10.1016/j.apsb.2020.12.009
18
Meng-Meng Gu, Ming Li, Dexuan Gao, Lang-Huan Liu, Yue Lang, Si-Ming Yang, Hongling Ou, Bo Huang, Ping-Kun Zhou, Zeng-Fu Shang. The vanillin derivative 6-bromine-5-hydroxy-4-methoxybenzaldehyde induces aberrant mitotic progression and enhances radio-sensitivity accompanying suppression the expression of PLK1 in esophageal squamous cell carcinomaToxicology and Applied Pharmacology 2018; 348: 76 doi: 10.1016/j.taap.2018.04.021
19
Chung S. Yang, Xiaoxin Chen, Shuiping Tu. Etiology and Prevention of Esophageal CancerGastrointestinal Tumors 2016; 3(1): 3 doi: 10.1159/000443155
20
Pan Pan, Daniel S. Peiffer, Yi-Wen Huang, Kiyoko Oshima, Gary D. Stoner, Li-Shu Wang. Inhibition of the development of N-nitrosomethylbenzylamine-induced esophageal tumors in rats by strawberries and aspirin, alone and in combinationJournal of Berry Research 2018; 8(2): 137 doi: 10.3233/JBR-170291
21
Dohee Kwon, Ji Yun Yun, Bhumsuk Keam, Young Tae Kim, Yoon Kyung Jeon. Prognostic implications of <i>FGFR1</i> and <i>MYC</i> status in esophageal squamous cell carcinomaWorld Journal of Gastroenterology 2016; 22(44): 9803-9812 doi: 10.3748/wjg.v22.i44.9803
22
Yahui Li, Qing Cheng, Zhaohui Xiong, Chorlada Paiboonrungruang, Timothy Adekoya, Yong Li, Xiaoxin Chen. Lymphatic Drainage System and Lymphatic Metastasis of Cancer Cells in the Mouse EsophagusDigestive Diseases and Sciences 2023; 68(3): 803 doi: 10.1007/s10620-022-07586-6
23
Poojarani Panda, Henu Kumar Verma, Lakkakula V. K. S. Bhaskar. Precision Medicine Revolutionizing Esophageal Cancer Treatment: Surmounting Hurdles and Enhancing Therapeutic Efficacy through Targeted Drug TherapiesOnco 2023; 3(3): 127 doi: 10.3390/onco3030010
24
Yumiao Zhao, Jiaxin Sun, Yin Li, Xiuman Zhou, Wenjie Zhai, Yahong Wu, Guanyu Chen, Shanshan Gou, Xinghua Sui, Wenshan Zhao, Lu Qiu, Yongjie Yao, Yixuan Sun, Chunxia Chen, Yuanming Qi, Yanfeng Gao. Tryptophan 2,3-dioxygenase 2 controls M2 macrophages polarization to promote esophageal squamous cell carcinoma progression via AKT/GSK3β/IL-8 signaling pathwayActa Pharmaceutica Sinica B 2021; 11(9): 2835 doi: 10.1016/j.apsb.2021.03.009
25
Xueyin Zu, Xiaomeng Xie, Yuanyuan Zhang, Kangdong Liu, Ann M. Bode, Zigang Dong, Dong Joon Kim. Lapachol is a novel ribosomal protein S6 kinase 2 inhibitor that suppresses growth and induces intrinsic apoptosis in esophageal squamous cell carcinoma cellsPhytotherapy Research 2019; 33(9): 2337 doi: 10.1002/ptr.6415
26
Qingjie Min, Yan Wang, Qingnan Wu, Xianfeng Li, Huajing Teng, Jiawen Fan, Yiren Cao, Pingsheng Fan, Qimin Zhan. Genomic and epigenomic evolution of acquired resistance to combination therapy in esophageal squamous cell carcinomaJCI Insight 2021; 6(17) doi: 10.1172/jci.insight.150203
27
Xing He, Hezhong Yan, Jie Hu, Xiaowei Duan, Mingjin Zhang, Haiqing Li, Jiaoxue Wang, Qian Gao, Senyuan Yu, Xilu Hou, Guobin Liao, Shicun Guo, Jin Li, Yurong Ge, Xiaolan Chen, Wenchao Wang, Jun Tang. HDS screening with patient-derived primary cells guided individualized therapy for esophageal squamous cell carcinoma–in vivo and vitroFrontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1212851
28
Yong Li, Yahui Li, Xiaoxin Chen. Notch Signaling in Embryology and CancerAdvances in Experimental Medicine and Biology 2021; 1287: 59 doi: 10.1007/978-3-030-55031-8_5
29
Nuo Li, Yang Yu, Baoming Wang. Downregulation of AAA-domain-containing protein 2 restrains cancer stem cell properties in esophageal squamous cell carcinoma via blockade of the Hedgehog signaling pathwayAmerican Journal of Physiology-Cell Physiology 2020; 319(1): C93 doi: 10.1152/ajpcell.00133.2019
30
Qi Wang, Sheng Zhong, Hua Wu, Qingquan Wu. In vitro anti-cancer effect of marmesin by suppression of PI3K/Akt pathway in esophagus cancer cellsEsophagus 2022; 19(1): 163 doi: 10.1007/s10388-021-00872-8
31
Yongjing Liu, Zhaohui Xiong, Andrea Beasley, Thomas D'Amico, Xiaoxin Luke Chen. Personalized and targeted therapy of esophageal squamous cell carcinoma: an updateAnnals of the New York Academy of Sciences 2016; 1381(1): 66 doi: 10.1111/nyas.13144
32
Rui Xie, Shang-Nong Wu, Cheng-Cheng Gao, Xiao-Zhong Yang, Hong-Gang Wang, Jia-Ling Zhang, Wei Yan, Tian-Heng Ma. MicroRNA-30d inhibits the migration and invasion of human esophageal squamous cell carcinoma cells via the post-transcriptional regulation of enhancer of zeste homolog 2Oncology Reports 2017; 37(3): 1682 doi: 10.3892/or.2017.5405
33
Abolfazl Rad, Saeed Esmaeili Dizghandi, Mohammad Reza Abbaszadegan, Negin Taghechian, Maryam Najafi, Mohammad Mahdi Forghanifard. SOX1 is correlated to stemness state regulator SALL4 through progression and invasiveness of esophageal squamous cell carcinomaGene 2016; 594(2): 171 doi: 10.1016/j.gene.2016.08.045
34
Haidi Huang, Yu Jiang, Jiangying Liu, Dan Luo, Jianghong Yuan, Rongzi Mu, Xiang Yu, Donglei Sun, Jihong Lin, Qiyue Chen, Xinjing Li, Ming Jiang, Jianming Xu, Bo Chu, Chengqian Yin, Lei Zhang, Youqiong Ye, Bo Cao, Qiong Wang, Yongchun Zhang. Jag1/2 maintain esophageal homeostasis and suppress foregut tumorigenesis by restricting the basal progenitor cell poolNature Communications 2024; 15(1) doi: 10.1038/s41467-024-48347-5
35
Jialin Li, Ming Li, Feng Gao, Xiaojun Ge. Serum microRNA-15a level acts as a potential diagnostic and prognostic biomarker for human esophageal squamous cell carcinomaCancer Biomarkers 2017; 18(1): 11 doi: 10.3233/CBM-160667
36
Ya‐Tian Liu, Dan Zong, Xue‐Song Jiang, Li Yin, Li‐Jun Wang, Ting‐Ting Wang, Jun Zhu, Xia He. miR‐32 promotes esophageal squamous cell carcinoma metastasis by targeting CXXC5Journal of Cellular Biochemistry 2019; 120(4): 6250 doi: 10.1002/jcb.27912
37
Heng Xu, Haixia Cao, Junying Zhang, Changwen Jing, Zhuo Wang, Jianzhong Wu, Mengjie Du, Xuyun Xu, Rong Ma. Serum VEGF levels as a predictor of recurrence in patients with advanced‑stage esophageal squamous cell carcinoma following curative esophagectomy followed by chemotherapy or concurrent radiotherapyMolecular and Clinical Oncology 2023; 19(5) doi: 10.3892/mco.2023.2682